DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $27.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price lowered by Evercore ISI from $28.00 to $27.00 in a research note issued to investors on Tuesday morning, Benzinga reports. Evercore ISI currently has an outperform rating on the medical instruments supplier’s stock.

Other analysts have also recently issued research reports about the stock. Piper Sandler reiterated a neutral rating and set a $32.00 price target (down previously from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. The Goldman Sachs Group reduced their target price on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a neutral rating for the company in a research note on Monday, May 6th. Needham & Company LLC reduced their target price on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating for the company in a research note on Friday, May 3rd. Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating for the company in a research note on Friday, May 3rd. Finally, Barrington Research restated an outperform rating and issued a $38.00 target price on shares of DENTSPLY SIRONA in a research note on Monday. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of Moderate Buy and a consensus target price of $34.33.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY opened at $25.71 on Tuesday. The firm has a fifty day moving average price of $26.72 and a 200 day moving average price of $31.13. The company has a current ratio of 1.43, a quick ratio of 0.97 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA has a 1-year low of $23.94 and a 1-year high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.42. The firm had revenue of $953.00 million during the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. DENTSPLY SIRONA’s quarterly revenue was down 2.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.39 EPS. On average, equities analysts anticipate that DENTSPLY SIRONA will post 2.02 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 12th. Stockholders of record on Friday, June 28th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.49%. DENTSPLY SIRONA’s dividend payout ratio is presently -145.45%.

Insider Activity

In related news, Director Gregory T. Lucier purchased 3,577 shares of the business’s stock in a transaction dated Friday, May 31st. The stock was acquired at an average price of $27.95 per share, for a total transaction of $99,977.15. Following the acquisition, the director now directly owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 0.52% of the company’s stock.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in DENTSPLY SIRONA by 1.5% during the 3rd quarter. Vanguard Group Inc. now owns 25,250,443 shares of the medical instruments supplier’s stock valued at $862,555,000 after acquiring an additional 369,213 shares in the last quarter. Nuance Investments LLC increased its holdings in DENTSPLY SIRONA by 30.4% during the 4th quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier’s stock valued at $412,982,000 after acquiring an additional 2,702,457 shares in the last quarter. First Eagle Investment Management LLC increased its holdings in DENTSPLY SIRONA by 1.2% during the 4th quarter. First Eagle Investment Management LLC now owns 9,786,845 shares of the medical instruments supplier’s stock valued at $348,314,000 after acquiring an additional 120,508 shares in the last quarter. Wellington Management Group LLP increased its holdings in DENTSPLY SIRONA by 21.1% during the 4th quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock valued at $289,640,000 after acquiring an additional 1,419,503 shares in the last quarter. Finally, Cooke & Bieler LP grew its holdings in shares of DENTSPLY SIRONA by 18.3% during the fourth quarter. Cooke & Bieler LP now owns 7,061,910 shares of the medical instruments supplier’s stock worth $251,333,000 after buying an additional 1,092,922 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.